Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 5, 1999, Pages 949-970

  Lijnen, P ^a,b   Petrov, V ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cardiomyocytes; Gene expression; Hypertrophy; Protein synthesis

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 4' [(2 CYCLOPROPYL 7 METHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL][1,1' BIPHENYL] 2 CARBOXYLIC ACID; ALPHA ACTIN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CANDESARTAN HEXETIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EK 739; EMBUSARTAN; ENALAPRIL; GROWTH FACTOR; IMIDAPRIL; LISINOPRIL; LOSARTAN; PERINDOPRIL; PROTEIN; QUINAPRIL; RAMIPRIL; SAPRISARTAN; TELMISARTAN; TRANDOLAPRIL; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

CELL CULTURE; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMEDIATE EARLY GENE; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0033136571     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0934     Document Type: Review

References (149)

1. Abdellatif MM, Neubauer CF, Lederer WJ, Rogers TB, 1991. Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ Res 69: 800-809.
2. Baker KM, Booz GW, Dostal DE, 1992. Cardiac actions of angiotensin II. Role of an intracardiac renin-angiotensin system. Ann Rev Physiol 54: 227-241.
3. Baker KM, Chernin MI, Wixson SK, Aceto JF, 1990. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 259: H324-H332.
4. Böhm M, Lippoldt A, Wienen W, Ganten D, Bader M, 1996. Reduction of cardiac hypertrophy in TGR (m Ren 2) 27 by angiotensin II receptor blockade. Mol Cell Biochem 163/164: 217-221.
5. Booz GW, Baker KM, 1996. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28: 635-640.
6. Brilla CG, Scheer C, Rupp H, 1997. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J Hypertens 15 (Suppl. 6): S13-S19.
7. Brilla CG, Janicki JS, Weber KT, 1991. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 83: 1771-1779.
8. Brilla CG, Matsubara L, Weber KT, 1996. Advanced hypertensive heart disease in spontaneously hypertensive rats. Hypertension 28: 269-275.
9. Brodsky S, Gurbanov K, Abassi Z, Hoffmann A, Ruffolo RR Jr, Feuerstein GZ, Winaver J, 1998. Effects of eprosartan on renal function and cardiac hypertrophy with experimental heart failure. Hypertension 32: 746-752.
10. Brooks WW, Bing OHL, Conrad CH, O'Neill L, Crow MT, Lakatta EG, Dostal DE, Baker KM, Boluyt MO, 1997. Captopril modified gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats. Hypertension 30: 1362-1368.
11. Cao L, Gardner DG, 1995. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25: 227-234.
12. 1 receptor blockade on cardiac pump performance after myocardial infarction in rats. J Cardiovasc Pharmacol 23: 584-593.
13. Ceiler DL, Marjorri HJ, Nelissen-Vrancken G, De Mey JGR, Smiths JFM, 1998. Effect of chronic blockade of angiotensin II receptor subtypes on aortic compliance in rats with myocardial infarction. J Cardiovasc Pharmacol 31: 630-637.
14. Childs TJ, Adams MA, Mak AS, 1990. Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 16: 662-668.
15. Claycomb WC, 1983. Cardiac muscle cell proliferation and cell differentiation in vivo and in vitro. Adv Exp Med Biol 161: 249-265.
16. Danilov SM, Chumachenko PV, Andreeva YV, Printseva OY, Lacis RV, 1993. Angiotensin converting enzyme expression in the inflammation zone of human myocardial infarction and rat model of skin injury. J Hypertens 5: S232-S233.
17. Decker MJ, Belmkebarclay M, Cook MG, Lesch M, Decker RS, 1991. Morphometric evaluation of the contractile apparatus in primary cultures of rabbit cardiac myocytes. Circ Res 69: 86-94.
18. de Lannoy LM, Danser AHJ, van Kats JP, Schoemaker RG, Saxena PR, Schalenkamp Madh, 1997. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart: Local production of angiotensin I. Hypertension 29: 1240-1251.
19. de Lannoy LM, Danser AHJ, Bouhuizen AMB, Saxena PR, Schalekamp Madh, 1998. Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension 31: 1111-1117.
20. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S, 1997. Compartmentalization of angiotensin II generation in the dog heart. J Clin Invest 100: 253-258.
21. de Simone G, Devereux RB, Camargo MJF, Wallerson DC, Sealey JE, Laragh JH, 1996. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. Am J Hypertens 9: 216-222.
22. Diez J, Panizo A, Hernández M, Vega F, Sola I, Fortuno MA, Parda J, 1997. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30: 1029-1034.
23. Dostal DE, Baker KM, 1992. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: Mediation by AT1 receptor. Am J Hypertens 5: 276-280.
24. Dostal DE, Hunt RA, Kule CE, Bhat CJ, Karoor V, Mcwhinney CD, Baker KM, 1997. Molecular mechanisms of angiotensin II in modulating cardiac function: Intracardiac effects and signal transduction pathways. J Mol Cell Cardiol 29: 2823-2902.
25. Dostal DE, Rothblum KN, Chernin MI, Cooper GR, Baker KM, 1992. Intracardiac detection of angiotensinogen and renin: A localized renin-angiotensin system in neonatal rat heart. Am J Physiol 263: C838-C850.
26. Dostal DE, Rothblum KN, Conrad KM, Cooper GR, Baker K, 1992. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol 263: C851-C863.
27. Duncan AM, Burrell LM, Kladis A, Campbell DJ, 1996. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol 28: 746-754.
28. Dusaillant GR, Gonzalez H, Cespedes C, Jalil JE, 1996. Regression of left ventricular hypertrophy in experimental renovascular hypertension: Diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass. J Hypertens 14: 1117-1123.
29. Dzau VJ, 1988. Cardiac renin-angiotensin system. Am J Med 88: 22-27.
30. Eppenberger ME, Hauser I, Baechi T, Schaub MC, Brunner UT, Dechesne CA, Eppenberger HM, 1988. Immunocytochemical analysis of the regeneration of myofibrils in long-term cultures of adult cardiocytes of the rat. Dev Biol 130: 1-15.
31. Eppenberger-Eberhardt M, Aigner S, Donath MY, Kurer V, Walther P, Zuppinger C, Schaub MC, Eppenberger HM, 1997. IGF-1 and bfgf differentially influence atrial natriuretic factor and α-smooth muscle actin expression in cultured atrial compared to ventricular adult rat cardiomyocytes. J Mol Cell Cardiol 29: 2027-2039.
32. Eppenberger-Eberhardt M, Flamme I, Kurer V, Eppenberger HM, 1990. Reexpression of alpha-smooth muscle actin isoform in cultured adult rat cardiomyocytes. Dev Biol 139: 269-278.
33. Eppenberger-Eberhardt M, Messerli M, Eppenberger HM, Reinecke M, 1993. New occurrence of atrial natriuretic factor and storage in secretorially active granules in adult rat ventricular cardiomyocytes in long-term culture. J Mol Cell Cardiol 25: 753-757.
34. 1 receptor gene regulation in cardiac myocytes and fibroblasts. J Mol Cell Cardiol 28: 1727-1736.
35. 1 expression. Hypertension 23: 587-592.
36. Falkenhaln MF, Franke F, Bohle RM, Zhu YC, Strauss HM, Bachmann S, Danilov S, Unger T, 1995. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25: 219-226.
37. 2+-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 15: 1001-1009.
38. Fujii N, Tanaka M, Ohmishi J, Yukawa K, Takimoto E, Shimada S, Naruse M, Sugiyama F, Yagami K, Murakami K, Miyazaki H, 1995. Alterations of angiotensin II receptor contents in hypertrophied hearts. Biochem Biophys Res Commun 212: 326-333.
39. Fuller SJ, Gaitanaki CJ, Sugden PH, 1990. Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Biochem J 266: 727-736.
40. Geenen DL, Malhotra A, Scheuer J, 1993. Angiotensin II increases protein synthesis in adult rat heart. Am J Physiol 265: H238-H243.
41. Glennon PE, Sugden PH, Poole-Wilson PA, 1995. Cellular mechanism of cardiac hypertrophy. Br Heart J 73: 496-499.
42. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS, 1998. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β and endothelin from fibrolasts. Cardiovasc Res 40: 352-363.
43. Grimm D, Kromer EP, Böcker W, Bruckschlegel G, Holmer SR, Riegger GAJ, Schunkert H, 1998. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin converting enzyme inhibition. J Hypertens 16: 1345-1355.
44. Hanatani A, Yoshiyama M, Kim S, 1995. Inhibition by angiotensin II type receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27: 1905-1914.
45. Harada K, Komuro I, Shiojima I, Hayashi D, Kudoh S, Mizuno T, Kijima K, Matsubara H, Sagaya T, Murakami K, Yazaki Y, 1998a. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 97: 1952-1959.
46. Harada K, Komuro I, Zou Y, Kudoh S, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y, 1998b. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ Res 82: 779-785.
47. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Iguki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K, 1997. Significance of ventricular myocytes and nonmyocytes during cardiocyte hypertrophy. Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96: 3737-3744.
48. Hefti MA, Harder BA, Eppenberger HM, Schaub MC, 1997. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 29: 2873-2892.
49. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ, 1991. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69: 475-482.
50. Inagami T, 1998. A memorial to robert tiegerstedt. The centennial of renin discovery. Hypertension 32: 953-957.
51. Iwai N, Shimoike H, Kinoshita M, 1995. Cardiac renin-angiotensin system in the hypertrophied heart. CirCulation 92: 2690-2696.
52. Izumo S, Nadal-Ginard B, Mahdavi V, 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339-343.
53. Jalil JE, Janicki JS, Pick R, Weber KT, 1991. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril. Am J Hypertens 4: 51-55.
54. Ju H, Zhao S, Jassal DS, Dixon IMC, 1997. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res 35: 223-232.
55. Kalenikova EI, Gorodetskaya EA, Zacharova NV, Shechter AB, Medvedev OS, 1998. Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats. J Cardiovasc Pharmacol 32: 608-615.
56. Kaneko K, Susic D, Nunez E, Frohlich EP, 1996. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J Hypertens 14: 645-653.
57. Kannel WB, Levy D, Cupples LA, 1987. Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham study. J Cardiovasc Pharmacol 10: S135-S140.
58. Karam H, Heudes D, Hess P, Gonzales MF, Löffler BM, Clozel M, Clozel JP, 1996. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 31: 287-295.
59. Katoh Y, Komuro I, Shibasaki Y, Yamaguchi H, Yazaki Y, 1989. Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes. Circulation 80: II-450.
60. Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT, 1997. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 29: 1375-1386.
61. Kent RL, Mcdermott PJ, 1996. Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiac myocytes. Circ Res 78: 829-838.
62. Khairallah PA, Kanabus J, 1983. Angiotensin and myocardial protein synthesis. Perspect Cardiovasc Res 8: 337-347.
63. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaki T, Inada M, 1996. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res 79: 887-897.
64. Kim NN, Villareal FJ, Printz MP, Lee AA, Dillmann WH, 1995. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol 269: E426-E437.
65. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H, 1994. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24: 195-204.
66. 1 and extracelular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 273: 509-515.
67. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Iwao H, 1995. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25: 1252-1259.
68. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Y, Wang Y, Mizumo T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y, 1994. Angiotensin II receptor antagonist TCV 116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2204-2211.
69. Komuro I, Kurabagashi M, Takaku F, Yazaki Y, 1988. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-over-loaded hypertrophy of the rat heart. Circ Res 62: 1075-1079.
70. Lee MA, Böhm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D, 1995. Differential gene expression of renin and angiotensinogen in the TGR (m Ren 2) 27 transgenic rat. Hypertension 25: I570-I580.
71. Lindpaintner K, Ganten D, 1991. The cardiac renin-angiotensin system: An appraisal of present experimental and clinical evidence. Circ Res 68: 905-921.
72. Linz W, Schölkens BA, Han JF, 1986. Beneficial effects of the converting enzyme inhibitor ramipril in ischemic rat heart. J Cardiovasc Pharmacol 3: S91-S99.
73. Linz W, Schölkens BA, Ganten D, 1989. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A11: 1325-1350.
74. Liu YH, Yang XP, Sharov VG, Carretero OA, 1996. The role of angiotensin II type II receptor in the effect of chronic blockade of angiotensin II type I receptor on heart failure in rats. Hypertension 28: 512-518.
75. Long CS, Hartogensis WE, Simpson PC, 1993. β-adrenergic stimulation of cardiac non-myocytes augmented for growth-promoting activity of non-myocytes conditioned medium. J mol cell cardiol 25: 915-925.
76. Long CS, Henrich CI, Simpson PC, 1991. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Reg 2: 1081-1085.
77. Long CS, Ordahl CP, Simpson PC, 1989. Alpha-1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J Clin Invest 83: 1078-1082.
78. 2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 267: H844-H852.
79. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T, 1996. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol 28: 507-517.
80. Makino N, Sugano M, Otsuka S, Hata T, 1977. Molecular mechanism of angiotensin II type 1 and type 2 receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 30: 796-802.
81. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Imada M, 1994. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 93: 1592-1601.
82. Meggs LG, Coupet J, Huang H, Li WCP, Capasso JM, Homcy CJ, Anversa P, 1993. Regulation of angiotensin II receptor on ventricular myocytes after myocardial infarction in rats. Circulation 83: 13-25.
83. Michel JB, Lattion AL, Salzmann JL, 1988. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 62: 641-650.
84. Mitcheson JS, Hancox JC, Levi AJ, 1998. Cultured adult myocytes: Future applications, culture methods, morphological and electrophysiological aspects. Cardiovasc Res 39: 280-300.
85. Miyata S, Haneda T, 1994. Hypertrophic growth of cultured neonatal heart cells mediated by type I angiotensin receptor. Am J Physiol 266: H2443-H2451.
86. Moalic JH, Bautens C, Himbert D, Bercovici J, Mouas C, Guicheney P, Baudoin-Legros M, Rappaport L, Emanoil-Ravier R, Mezger V, 1989. Phenylephrine, vasopressin and angiotensin II as determinants of proto-oncogene and heart-shock protein gene expression in adult rat heart and aorta. J Hypertens 7: 195-201.
87. Morgan HE, Baker KM, 1991. Cardiac hypertrophy. Mechanical, neural and endocrine dependence. Circulation 83: 13-25.
88. Müller DN, Fischli W, Clozel JP, Hilgers KF, Bohlender J, Ménard J, Basjahn A, Ganten D, Luft FC, 1998. Local angiotensin II generation in the rat heart. Role of renin uptake. Circ Res 82: 13-20.
89. Mullins JJ, Peeters J, Ganten D, 1990. Fulminant hypertension in transgenic rats harbouring the mouse Ren 2 gene. Nature 344: 541-544.
90. Nagano M, Higaki J, Mikami H, Nakamaru M, Higashimori K, Katahira K, Tabuchi A, Nakamura F, Ogihara T, 1991. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens 9: 595-599.
91. Nay AC, Cheng M, 1986. Biochemical evidence for cellular dedifferentiation in adult rat cardiac muscle cells in culture: Expression of myosin isozymes. Biochim Biophys Res Commun 137: 855-862.
92. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Imada M, 1995. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95: 46-54.
93. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, Eid H, Schölkens BA, de Bold AJ, 1996. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 93: 2059-2067.
94. Ohta K, Kim S, Iwao H, 1996a. Role of angiotensin-converting enzyme, adrenergic receptors and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension 28: 627-634.
95. Ohta K, Kim S, Wanibuchi H, Ganten D, Iwao H, 1996b. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation and remodeling in TGR (m Ren 2) 27 transgenic rats. Circulation 94: 785-791.
96. Onodera T, Tamura T, Said S, Mccane SA, Gerdes AM, 1998. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32: 753-757.
97. Pahor M, Bernabei R, Sgadari A, Gambassi G Jr, La Giuduce PL, Pacifici L, Ramacci MT, Lagiasta C, Olivetti G, Carbonin P, 1991. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18: 148-157.
98. Panizio A, Parolo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J, 1995. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 8: 815-822.
99. Passier RCJJ, Smits JFM, Verluyten MJA, Studer R, Drexler H, Daenen MJAP, 1995. Activation of angiotensin-converting-enzyme expression in the infarct zone following myocardial infarction. Am J Physiol 269: H1268-H1276.
100. Passier RC, Smits JF, Verluyten MJ, Daenen MJ, 1996. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 271: H1040-H1048.
101. Petrov V, Fagard R, Lijnen P, 1999. Transforming Growth Factor-β Induced Differentiation of Cardiac Fibroblasts to Myofibroblasts is Accompanied by an Increase in Angiotensin Converting Enzyme Activity. Submitted for publication.
102. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E, 1983. Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat. Eur Heart J 4: A143-A148.
103. Pinto J, Vigliane P, Saaveda J, 1991. Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens 4: 321-326.
104. Pinto YM, de Smet BGJL, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H, 1993. Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: Relation to ventricular function and morphology. Cardiovasc Res 27: 1933-1938.
105. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E, 1995. Regulation, chamber localization and subtype distribution of angiotensin II receptors in human hearts. Circulation 91: 1461-1471.
106. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF, 1992. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 20: 147-156.
107. Rogers TB, Gaa ST, Allen IS, 1986. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 236: 438-444.
108. Rossi MA, Peres LC, 1992. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy. Am Heart J 124: 700-709.
109. Ruzicka M, Yuan B, Leenen FHH, 1994. Effects of enalapril versus losartan on regression of volume over-load-induced cadiac hypertrophy in rats. Circulation 90: 484-491.
110. Sadoshima J, Takahashi T, Jahn L, Izumo S, 1992. Roles of mechanosensitive ion channels, cytoskeleton and contractile activity in stretch-induced immediate-early gene expression and hypertrophy of cardiac myocytes. Proc Natl Ac ad Sci USA 89: 9905-9909.
111. Sadoshima J, Izumo S, 1993a. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Cire Res 73: 413-423.
112. Sadoshima J, Izumo S, 1993b. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: Role of phospholipidderived second messengers. Circ Res 73: 424-438.
113. Sadoshima J, Xu Y, Slayter HS, Izumo S, 1993c. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
114. Sadoshima J, Izumo S, 1996. The heterotrimeric G(Q) protein-coupled angiotensin II receptor activates p21(ras) via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15: 775-787.
115. Saito K, Gutkind JS, Saavedra JM, 1987. Angiotensin II binding site in the conduction system of rat hearts. Am J Physiol 253: H1618-H1622.
116. Sarvazyan N, 1998. A new approach to assess viability of adult cardiocytes: Computer-assisted image analysis. J Mol Cell Cardiol 30: 297-301.
117. Schieffer B, Winger A, MEybrunn M, 1994. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type II receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282.
118. Schoemaker R, Debets J, Struyker-Boudier H, Smits J, 1991. Delayed but not immediate captopril therapy improves cardiac function in concious rats, following myocardial infarction. J Mol Cell Cardiol 23: 187-197.
119. Schölkens BA, Linz W, Martorana PA, 1991. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: Beyond the blood pressure. J Cardiovasc Pharmacol 18: S26-S30.
120. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH, 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: Effects on coronary resistance, contractility, and relaxation. J Clin Invest 86: 1913-1920.
121. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH, 1995. Angiotensin II-induced growth responses in isolated adult rat hearts. Circ Res 76: 482-497.
122. Sechi LA, Griffin CA, Crady EK, Kalinyak JE, Schambelan M, 1992. Characterization of angiotensin II receptor subtype in rat heart. Circ Res 71: 1482-1489.
123. SEn S, Tarazi RC, Bumpus FM, 1980. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension 2: 169-176.
124. Shyu KG, Chen JJ, Shih NL, Chang H, Wang DL, Lien WP, Liew CC, 1995. Angiotensinogen gene expression is induced by cyclical mechanical stretch in cultured rat cardiomyocytes. Biochem Biophys Res Commun 211: 241-248.
125. Sil P, Sen S, 1997. Angiotensin II and myocyte growth. Role of fibroblasts. Hypertension 30: 209-216.
126. Smits JFM, Van Krimpen C, Schoemaker RG, Cleutjens JPM, MJAP, 1992. Angiotensin II receptor blockade after myocardial infarciton in rats: Effects on hemodynamics, myocardial DNA synthesis and interstitial collagen content. J Cardiovasc Pharmacol 20: 772-778.
127. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H, 1994. Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 94: 301-310.
128. Sun Y, Cleutjens JP, Diaz-Arias AA, Weber KT, 1994. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28: 1423-1432.
129. Sun Y, Weber KT, 1996. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28: 851-858.
130. Susic D, Nuñez E, Frohlich ED, Prakash O, 1996. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension 28: 265-268.
131. Suzuki J, Matsubara H, Urakami M, Imada M, 1993. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73: 439-447.
132. Takahushi K, Azuma M, Taira K, Baba A, Yamamoto I, Schaffer SW, Azuma J, 1997. Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J Cardiovas Pharmacol 30: 725-730.
133. Taylor K, Patten RD, Smith JJ, Aronovitz MJ, Wight J, Salomon RN, Konstam MA, 1998. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc Pharmacol 31: 654-660.
134. Teismann ACH, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, van Gilst WH, 1998. Dissociation of blood pressure reduction from end-organ damage in TGR (mRen2) 27 transgenic hypertensive rats. J Hypertens 16: 1759-1765.
135. Unger T, Mattfeldt T, Lamberty V, Block P, Mall G, Linz W, Schölkens BA, Gohlke P, 1992. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 20: 478-482.
136. van Bilsen M, Chien KR, 1993. Growth and hypertrophy of the heart: Towards an understanding of cardiac specific and inducible gen expression. Cardiovasc Res 27: 1140-1149.
137. van Kesteren CAM, Danser AHJ, Derckx FHM, Dekkers DHW, Lamers JMJ, Saxena PR, Schalekamp Madh, 1997. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 30: 1389-1396.
138. van Kesteren CAM, van Heugten HAA, Lamers JMJ, Saxena PR, Schalekamp MADH, Danser AHJ, 1997. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 29: 2147-2157.
139. Van Krimpen C, Smits JFM, Cleutjens JPM, 1991. DNA synthesis in the non-infarcted cardiac interstitium is increased after left coronary artery ligation in the rat: Effect of captopril. J Mol Cell Cardiol 23: 1245-1253.
140. Weber KT, Brilla CG, 1991. Pathological hypertrophy and cardiac interstitium: Fibrosis and the renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
141. Wiesner RJ, Zak R, 1991. Quantitative approaches for studying gene expression. Am J Physiol 260: L179-L188.
142. Wolf K, Della Bruna R, Bruckschlegel G, Schunkert H, Riegger GA, Kurtz A, 1996. Angiotensin II receptor gene expression in hypertrophied left ventricles of rat hearts. J Hypertens 14: 349-354.
143. Woodcock EA, Tanner JK, Fullerton M, Kuraja IJ, 1992. Different pathways of inositol metabolism in intact neonatal rat hearts and isolated cardiomyocytes. Biochem J 281: 683-688.
144. Yamada H, Fabris B,Allen A, Jackson B, Johnston C, Mendelsohn F, 1991. Localization of angiotensin converting enzyme in rat heart. Circ Res 68: 141-149.
145. Yang CM, Kandaswamy V, Young D, Sen S, 1997. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. Cardiovasc Res 36: 236-245.
146. Yonezawa T, Umemoto S, Fujii A, Katayama K, Mtsuzaki M, 1996. Comparative effects of type I angiotensin II-receptor blockade with angiotensin-converting-enzyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats. J Cardiovasc Pharmacol 27: 119-124.
147. Yoshida K, Kohzuki M, Casley DJ, Johnston CI, 1998. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction. J Cardiovasc Pharmacol 32: 357-365.
148. Zak R, 1973. Cell proliferation during cardiac growth. Am J Cardiol 31: 211-219.
149. Zhou J, Allen AM, Yamada H, Sun Y, Mendelsohn Fao, 1994. Localization and properties of the angiotensin-converting enzyme and angiotensin receptors in the heart. In: Lindpainter K, Ganten D (eds) The Cardiac Renin Angiotensin System. New York: Futura, pp 63-88.